Modern medical technologies in pediatric oncology: organ-preserving treatment for malignant solid tumors
- Authors: Durnov L.A.1,2, Goldobenko G.V.1,2, Sharoev T.A.1,2, Polyakov V.G.1,2, Ivanova N.M.1,2, Kazantsev A.P.1,2
-
Affiliations:
- Research Institute of Pediatric Oncology and Hematology (Director - Academician of the Russian Academy of Medical Sciences, Prof. L.A. Durnov)
- Research Institute of Clinical Oncology RONTS RAMS them. N.N. Blokhin (Director - Corresponding Member of the Russian Academy of Medical Sciences, Prof. M.I. Davydov)
- Issue: Vol 81, No 4 (2000)
- Pages: 249-253
- Section: Theoretical and clinical medicine
- URL: https://bakhtiniada.ru/kazanmedj/article/view/99777
- DOI: https://doi.org/10.17816/kazmj99777
- ID: 99777
Cite item
Full Text
Abstract
The successes achieved by pediatric oncologists represent the realization of the scientific and technological progress of modern times. The results of treatment of nephroblastoma, retinoblastoma, and bone sarcomas look especially demonstratively. The fact that at least 95% of children recover in the treatment of localized forms of nephroblastoma and retinoblastoma, and more than 50% of patients with bone sarcomas is considered commonplace and does not surprise pediatric oncologists. Unfortunately, the price of such results of therapy is often too high. A child whom we consider to have recovered from a malignant tumor, in fact, remains disabled since childhood due to the loss of a kidney or vision, or a limb.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
L. A. Durnov
Research Institute of Pediatric Oncology and Hematology (Director - Academician of the Russian Academy of Medical Sciences, Prof. L.A. Durnov); Research Institute of Clinical Oncology RONTS RAMS them. N.N. Blokhin (Director - Corresponding Member of the Russian Academy of Medical Sciences, Prof. M.I. Davydov)
Email: info@eco-vector.com
Russian Federation, Moscow
G. V. Goldobenko
Research Institute of Pediatric Oncology and Hematology (Director - Academician of the Russian Academy of Medical Sciences, Prof. L.A. Durnov); Research Institute of Clinical Oncology RONTS RAMS them. N.N. Blokhin (Director - Corresponding Member of the Russian Academy of Medical Sciences, Prof. M.I. Davydov)
Email: info@eco-vector.com
Russian Federation, Moscow
T. A. Sharoev
Research Institute of Pediatric Oncology and Hematology (Director - Academician of the Russian Academy of Medical Sciences, Prof. L.A. Durnov); Research Institute of Clinical Oncology RONTS RAMS them. N.N. Blokhin (Director - Corresponding Member of the Russian Academy of Medical Sciences, Prof. M.I. Davydov)
Email: info@eco-vector.com
Russian Federation, Moscow
V. G. Polyakov
Research Institute of Pediatric Oncology and Hematology (Director - Academician of the Russian Academy of Medical Sciences, Prof. L.A. Durnov); Research Institute of Clinical Oncology RONTS RAMS them. N.N. Blokhin (Director - Corresponding Member of the Russian Academy of Medical Sciences, Prof. M.I. Davydov)
Email: info@eco-vector.com
Russian Federation, Moscow
N. M. Ivanova
Research Institute of Pediatric Oncology and Hematology (Director - Academician of the Russian Academy of Medical Sciences, Prof. L.A. Durnov); Research Institute of Clinical Oncology RONTS RAMS them. N.N. Blokhin (Director - Corresponding Member of the Russian Academy of Medical Sciences, Prof. M.I. Davydov)
Email: info@eco-vector.com
Russian Federation, Moscow
A. P. Kazantsev
Research Institute of Pediatric Oncology and Hematology (Director - Academician of the Russian Academy of Medical Sciences, Prof. L.A. Durnov); Research Institute of Clinical Oncology RONTS RAMS them. N.N. Blokhin (Director - Corresponding Member of the Russian Academy of Medical Sciences, Prof. M.I. Davydov)
Author for correspondence.
Email: info@eco-vector.com
Russian Federation, Moscow
References
Supplementary files
